REQUEST A DEMO
Total
USD $0.00
Search more companies

Au Biopharm (Serbia)

Main Activities: Department Stores
Full name: Au Biopharm Profile Updated: September 30, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Au Biopharm is based in Serbia. The head office is in Valjevo. It operates in the Department Stores industry. The company was established on April 16, 1997. 148 (2024) employees currently work for Au Biopharm. From the latest financial highlights, Au Biopharm reported a net sales revenue increase of 5.68% in 2024. Its total assets grew by 6.78% over the same period. Au Biopharm’s net profit margin increased by 0.14% in 2024.

Headquarters
Naselje Oslobodioci Valjeva A/5
Valjevo; Kolubara;

Contact Details: Purchase the Au Biopharm report to view the information.

Website: http://www.apotekabiopharm.co.rs

Basic Information
Total Employees:
Purchase the Au Biopharm report to view the information.
Registered Capital:
Purchase the Au Biopharm report to view the information.
Financial Auditors:
Purchase the Au Biopharm report to view the information.
Incorporation Date:
April 16, 1997
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Au Biopharm report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
5.68%
Total operating revenue
5.32%
Operating profit (EBIT)
27.71%
EBITDA
20.24%
Net Profit (Loss) for the Period
27.73%
Total Assets
6.78%
Total Equity
0.73%
Operating Profit Margin (ROS)
0.2%
Net Profit Margin
0.14%
Return on Equity (ROE)
2.69%
Debt/Equity
51.07%
Quick Ratio
0.07%
Cash Ratio
0.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?